glp-1 receptor agonist for weight loss Agonists as Treatments Type 2 Diabetes Is GLP-1 Safe for Weight

As this promising treatment for weight loss works toward FDA approval, it is not yet available via standard prescription

J Am Pharm Assoc 63(5):16431645 Lee YS, Jun HS (2016) Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control

These symptoms frequently manifest during the initial treatment phase, affecting approximately 50% to 60% of patients [8], but they generally diminish over time, with their occurrence being dose-dependent

Side Effects Although these medications are generally well tolerated, they can lead to uncomfortable side effects

Sleep Disorders Obstructive sleep apnea (OSA) represents a significant clinical breakthrough for GLP-1 RAs in sleep medicine, culminating in the historic FDA approval of tirzepatide (Zepbound) on December 20, 2024, as the first medication specifically indicated for moderate-to-severe OSA in adults with obesity [154]

Studies were excluded if they focused on pediatric populations, only reported emergency procedures, lacked a control group of GLP-1RA nonusers, or used limited International Classification of Diseases, Tenth Revision, and Clinical Modification (ICD-10-CM) codes for aspiration outcomes